Gill MR - Search Results

1

Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.

Jackson MR, Bavelaar BM, Waghorn PA, Gill MR, El-Sagheer AH, Brown T, Tarsounas M, Vallis KA. Jackson MR, et al. Among authors: gill mr. Cancer Res. 2019 Sep 15;79(18):4627-4637. doi: 10.1158/0008-5472.CAN-18-3594. Epub 2019 Jul 16. Cancer Res. 2019. PMID: 31311806 Free PMC article.

2

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition.

Gill MR, Harun SN, Halder S, Boghozian RA, Ramadan K, Ahmad H, Vallis KA. Gill MR, et al. Sci Rep. 2016 Aug 25;6:31973. doi: 10.1038/srep31973. Sci Rep. 2016. PMID: 27558808 Free PMC article.

3

Corrigendum: A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition.

Gill MR, Harun SN, Halder S, Boghozian RA, Ramadan K, Ahmad H, Vallis KA. Gill MR, et al. Sci Rep. 2016 Dec 22;6:39363. doi: 10.1038/srep39363. Sci Rep. 2016. PMID: 28004747 Free PMC article. No abstract available.

4

Targeted radionuclide therapy in combined-modality regimens.

Gill MR, Falzone N, Du Y, Vallis KA. Gill MR, et al. Lancet Oncol. 2017 Jul;18(7):e414-e423. doi: 10.1016/S1470-2045(17)30379-0. Lancet Oncol. 2017. PMID: 28677577 Review.

5

A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator.

Gill MR, Jarman PJ, Halder S, Walker MG, Saeed HK, Thomas JA, Smythe C, Ramadan K, Vallis KA. Gill MR, et al. Chem Sci. 2017 Nov 16;9(4):841-849. doi: 10.1039/c7sc03712k. eCollection 2018 Jan 28. Chem Sci. 2017. PMID: 29629151 Free PMC article.

6

¹¹¹In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.

Gill MR , Menon JU , Jarman PJ , Owen J , Skaripa-Koukelli I , Able S , Thomas JA , Carlisle R , Vallis KA . Gill MR , et al. Nanoscale. 2018 Jun 7;10(22):10596-10608. doi: 10.1039/c7nr09606b. Nanoscale. 2018. PMID: 29808844 Free PMC article.

7

Subcellular Targeting of Theranostic Radionuclides.

Bavelaar BM, Lee BQ, Gill MR, Falzone N, Vallis KA. Bavelaar BM, et al. Among authors: gill mr. Front Pharmacol. 2018 Sep 4;9:996. doi: 10.3389/fphar.2018.00996. eCollection 2018. Front Pharmacol. 2018. PMID: 30233374 Free PMC article. Review.

8

Transition metal compounds as cancer radiosensitizers.

Gill MR, Vallis KA. Gill MR, et al. Chem Soc Rev. 2019 Jan 21;48(2):540-557. doi: 10.1039/c8cs00641e. Epub 2018 Nov 30. Chem Soc Rev. 2019. PMID: 30499573 Review.

9

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation.

Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis KA, Carlisle R. Owen J, et al. Among authors: gill mr. J Control Release. 2020 Mar 10;319:222-233. doi: 10.1016/j.jconrel.2019.12.045. Epub 2019 Dec 28. J Control Release. 2020. PMID: 31891732

10

Metallointercalator [Ru(dppz)₂(PIP)]²⁺ Renders BRCA Wild-Type Triple-Negative Breast Cancer Cells Hypersensitive to PARP Inhibition.

Yusoh NA, Leong SW, Chia SL, Harun SN, Rahman MBA, Vallis KA, Gill MR, Ahmad H. Yusoh NA, et al. Among authors: gill mr. ACS Chem Biol. 2020 Feb 21;15(2):378-387. doi: 10.1021/acschembio.9b00843. Epub 2020 Jan 14. ACS Chem Biol. 2020. PMID: 31898884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters